Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • NHPS: Expert for...

    NHPS: Expert for strong regulation, cap on medical input prices

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-02-19T10:30:04+05:30  |  Updated On 19 Feb 2018 10:30 AM IST

    New Delhi: In order to make the ambitious National Health Protection Scheme (NHPS) successful, the government should introduce strong regulation and put a cap on prices of medical inputs including medicines and health implants, an expert has said.


    Touted as the world's largest government-funded health care programme, the (NHPS) aims at benefiting 10 crore families by providing coverage of up to Rs 5 lakh per family per year for secondary and tertiary health care.


    In an open letter to Prime Minister Narendra Modi, Dr G S Grewal, Member Core Committee of Alliance of Doctors on Ethical Healthcare (ADEH), said that "revolutionary measures need revolutionary reforms".


    Ideally, after the scheme was announced, one would have felt satisfied with being secured in case of a medical emergency but given the way the health and pharmaceutical sector is operating currently in the country, Rs 5 lakhs will appear to be "just peanuts", Grewal said.


    "We have a recent example of a corporate hospital charging Rs 17 lakhs for the treatment of dengue where even then the patient died," he said.


    "This requires strong regulation of the prices of the inputs. The government has put a cap on the prices of stents. It also needs to put a similar cap on other health implants. Besides, there has to be a cap on the prices of medicines."


    He pointed out that the medicines of same salts with different brand names sell at varied priced and the gullible patient is made to believe the expensive ones will be more effective and thus gets cheated of his precious money.


    "If the prices of the input costs are not regulated, Rs five lakhs will not provide any relief to the patients. There needs to be a strict and serious regulation of the prices of the medicines as also the charges on various medical investigations and diagnostic tests.


    "...all the inputs required in a healthcare from a needle to I/V sets, etc need to be capped as well. It is quite possible and very much doable particularly when we have a prime minister like Narendra Modi who cares," he said.


    He also said there was a need to put an end to commission business in the medical profession.


    He said that along with curbing unethical practices in the medical profession, the medical teaching needs a thorough revamp.


    Medical education has declined over the years and "money, not merit" drives especially private medical education, he said. "This has had a very harmful impact on the profession as we are not producing the best doctors we could produce otherwise."


    "For this, we need to strengthen the government institutions like the AIIMS, New Delhi and the PGI Chandigarh. Who should be producing good teachers for these institutions," he said.


    "If there is any sincerity in the government to make healthcare affordable, it should realize that money saved on capping the drugs and other medical inputs will save government billions of rupees which it pays as a reimbursement as well as free treatment to all government employees.


    "This is comparable to saving electricity by shifting to LED technology," he added. He also suggested that regulating bodies like Medical Council of India and state Medical Councils should not have any member or office-bearers with conflict of Interest.

    AIIMS New DelhiAlliance of Doctors on Ethical HealthcareDr G S GrewalMedical Council of Indiamedical inputNarendra ModiNational Health Protection SchemeNHPSPGI Chandigarhpharmaceutical sector
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok